FORMULATION AND PHARMACOKINETIC DETERMINATION OF GALLIC ACID IN EMBLICA OFFICINALIS
Objective: The present work was to formulate oral herbal tablets of Emblica officinalis extract and also with pure gallic acid, further to determine the dosage frequency through pharmacokinetic profiles obtained for the same.
Methods: The Emblica officinalis fruits were suitably extracted and the concentration of gallic acid in Emblica officinalis extract was estimated by HPTLC (High-Performance Thin Layer Chromatography) with a comparison to pure form. Tablets were prepared with extract and synthetic form through direct compression technique by varying the process and formulation parameters. The formulated tablets were administered to rabbit models and their pharmacokinetic profile was studied after withdrawing blood samples through HPLC (High-Performance Liquid Chromatography).
Results: The concentration of gallic acid in Emblica officinalis was found to be 8.21%. The pre and post compression parameters evaluated for the formulated batches found to be within the pharmacopoeial limits. The in vivo pharmacokinetic studies conducted in rabbit models showed that there were no significant differences with p-value between the pharmacokinetic data obtained for pure and extract gallic acid tablets. The Cmax was found to be 4.59Â±0.95 Âµg/ml in the extract form which was little low when compared to the pure form of 6.38Â±1.08 Âµg/ml. The t1/2 in the extract form was 6.0Â±0.33 h, whereas it was 4.92Â±0.36 h in the pure form of gallic acid.
Conclusion: The Emblica officinalis extract tablet showed average t1/2 of 6 h, so about every 6 h one tablet compared to 4 h of t1/2 for pure gallic acid tablet can be the dosing frequency for the rabbit.Â
2. Samanta MK, Mukherjee PK, Prasad MK and Suresh B, â€œDevelopment of Natural Products", Eastern Pharmacist,3, 2000, 23- 27.
3. Tamizhmani T, Mukherjee PK, Manimaran S and Suresh B, â€œIndian herbal drug development: problems and prospectsâ€, Pharma Times, 34; 2002: 13-14. 4.
4. Mahady GB, â€œGlobal harmonization of herbal claims," J Nutr.131, 2001:1120-1123.
5. Aoyagi M, Aneta M, Hayashi T, Shibata T and Hatakeyama Y, â€œPreparation and chemical evaluation of cnidiumofficinale," Hokkaidoritsu EiseiKen kyu Soho. 51; 2001: 97-99. 7.
6. Bylaite E, Venskutonis RP and Roozen JP, â€œInfluence of harvesting time on the composition of volatile components in different anatomical parts of lovage(LevisticumOfficinale Koch)â€, J Agric Food Chem. 46; 1998:3735- 3740.
7. Gray E, â€œAntioxidant potential of ferulic acid," Free radical boil med, 13, 1992, 435-448.
8. Scartezzini P, Antognoni F, Raggi MA, Poli F and Sabbiani C, â€œVitamin C content and antioxidant activity of the fruit and the Ayurvedic preparations of Emblica officinalis Gaertnâ€, J Ethnopharmacol, 2006,104,113â€“8.
9. Vani-T, Rajani M, Sarkar S and Shishoo CJ, â€œAntioxidant property of the Ayurvedic formulation Triphala and its constituentsâ€, Inter J Pharmacol 1997, 35,313â€“7.
10. Sethi PD, HPLC Quantitative analysis of pharmaceutical formulations,New Delhi, CBS Publishers, and distributors,1, 2000: 1-200.
11. Lieberman, Lachman, and J. B. Schwartz, Pharmaceutical dosage forms, Tablets, Edited by H. H Marcel Dekker: New York, Vol. I, 1989: 592.
12. Modasiya MK, Prajapati BG, Patel VM and Shah DA, â€œDesign and Characterization of Fast Disintegrating Tablets of Piroxicamâ€, Int J PharmTech Res,1(2), 2009, 353-357.
13. Gohel MC and Pranav D J, â€œA review on co-processed directly compressible Excipientsâ€, J Pharma Sci, 8(1), 2005, 76-93.
14. LY Galichet, Cellulose, Microcrystalline in Handbook of Pharmaceutical excipients. 5th edition. London, UK. Pharmaceutical Press 2006:132- 135.
15. Aulton ME, Pharmaceutics, The Science of Dosage Form Design. London, England: Churchill Livingston. 1988, 305-608.
16. United States pharmacopeia, 24/ National Formulary USP Conventional Inc. Rockville, MD. 2000; 19: 546-547.
17. Pharmacopoeia of India, New Delhi, Ministry of Health and Family Welfare, Government of India, Controller of Publications 1996.
18. Singla N, Gupta GD, Kholi K and Singla AK, A Discriminatory and Biorelevant Dissolution Test Method for Simvastatin Drug Products, 2009, 11-13.
19. Karan RS, Bhargava VK and Garg SK, â€œEffect of trikatu, an Ayurvedic Prescription, on the pharmacokinetic profile of rifampicin in rabbitsâ€, Jr. of Ethnopharmacology, 64,1999, 259â€“264.
20. Ghosh MN, Fundamentals of Experimental Pharmacology. 3rd ed. Hilton Company. Kolkata 2005: 192.
21. Rowland T. Clinical Pharmacokinetics: Concepts and Application, 2nd ed. Lea and Febizer, 1989, 407-512.
22. Kucuk A, KadÃ½oglu Y and Celebi F, â€œInvestigation of the Pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatographyâ€“diode array detector method using liquidâ€“liquid extractionâ€. Journal of Chromatography B. 1(2), 2005, 203-208.